| The Effects of Phenylephrine and Norepinephrine on Systemic and Pulmonary Hemodynamics in Patients with Pulmonary Hypertension. |
|
Jae Hyung Kim, Sang Beom Nam, Won Son Park, Hae Jin Park, Yong Woo Hong, Young Lan Kwak |
1Department of Anesthesiology, Yonsei University College of Medicine.
2Yonsei Cardiovascular Center and Research Institute, Yonsei University College of Medicine.
3Department of Anesthesiology, Hanyang University College of Medicine. |
|
|
|
|
| Abstract |
BACKGROUND
It is difficult to choose the appropriate drug when hypotension develops in patients with pulmonary hypertension (PH). There is no known drug to increase the systemic blood pressure (BP) without an increase of pulmonary arterial pressure (PAP). We observed the effects of phenylephrine (PE) and norepinehrine (NE) on systemic and pulmonary hemodynamics when hypotension was treated in patients with PH.
METHODS
Patients with PH (mean PAP > or = 25 mmHg, n = 28) were studied. When hypotension occurred (systolic BP < or = 100 mmHg, T1) after the induction of anesthesia, PE or NE was randomly infused to raise the systolic BP above 130 mmHg (T2) and 150 mmHg (T3). Hemodynamic variables were measured at T1, T2 and T3, and the ratio (RBP) of mean PAP to mean BP was calculated. The measurements were performed before skin incision to avoid the effects of surgical stimulation.
RESULTS
NE increased BP concomitantly with relatively small increase of PAP, meaning a decrease of RBP (P < 0.05) without any other changes of hemodynamic variables in all patients. However, PE could not raise BP above 130 mmHg in one third of patients, and decreased the cardiac index without a significant decrease of RBP.
CONCLUSIONS
NE increased BP and decreased RBP without tachycardia or any other hemodynamic disturbances. NE is considered to be a proper and safe drug to raise BP when hypotension occurs in patients with PH. |
| Key Words:
Blood pressure: hypertension; pulmonary; Drug: norepinephrine; phenylephrine |
|
PDF Links
Full text via DOI
Download Citation
